Investigadores
Inicio
Investigadores
Biocruces Health Reserach Institute (IIS Biocruces). Vizcaya.
Inmunoterapia Celular
Cristina Eguizabal Argaiz
Investigador principal
Grupo de Investigación: Biocruces Health Reserach Institute (IIS Biocruces). Vizcaya.
Juan Anguita Castillo
Investigador colaborador
Grupo de Investigación: Biocruces Health Reserach Institute (IIS Biocruces). Vizcaya.
Maite Álvarez Rodríguez
Investigador colaborador
Grupo de Investigación: Biocruces Health Reserach Institute (IIS Biocruces). Vizcaya.
Gajjala R.K.R., Díaz M., Lopez-Iturri P., Picallo I., D'Arrigo E., Rodríguez-Muiña S., Eguizabal C., Sojic N., Falcone F., del Campo F.J.. Nanomolar electrochemiluminescence via smartphone: Image encoding matters. Biosensors and Bioelectronics. 1 October 2026. DOI: 10.1016/j.bios.2026.118823.
Impacto: 10.5. Cuartil: Q1
(1er decil)
Ramesh G., Sebestyen Z., Deshantri A.K., Punt S., Martinez Sanchez E., Fernandez-Sojo J., Querol S., Hudecek M., Sanges C., Das R., Ballardini A., Eguizabal C., Geerts D., Ghavamzadeh A., Escamilla Gómez V., Juan M., Larsen T.S., Lesný P., Lysák D., Müller M., Perpiñá U., de Wilde S., Malard F., Hoogenboom J., Mooyaart J., Ruggeri A., Straetemans T., Kuball J.. Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition. Bone Marrow Transplantation. February 2026. DOI: 10.1038/s41409-025-02774-0.
Impacto: 5.2. Cuartil: Q1
Romayor I., Martín-Colomo S., Polo Y., Bello C., Basanta-Torres R., Manero-Roig I., Pardo-Rodríguez B., Luzuriaga J., Unda F., Sarasua J.R., Ibarretxe G., Larrañaga A., Eguizabal C., Pineda J.R.. Nanopatterned bioresorbable elastomeric scaffolds to promote neural, glial, and endothelial differentiation using human embryonic and induced pluripotent stem cells. Journal of Tissue Engineering. January-December 2026. DOI: 10.1177/20417314251373038.
Impacto: 7.0. Cuartil: Q1
Delgadillo J., Martin F., Carmona G., Canals J.M., Rio P., Eguizabal C., Prosper F., Avendaño-Solá C.. Regulatory Strategies for Accelerating the Translation of Gene Therapies to Clinical Practice: Focus on GMO Considerations. Human Gene Therapy. 26 September 2025. DOI: 10.1177/10430342251372063.
Impacto: 4.0. Cuartil: Q1
Gonzaga A., Martinez-Navarrete G., Macia L., Anton-Bonete M., Cahuana G., Tejedo J.R., Zorrilla-Muñoz V., Fernandez-Jover E., Andreu E., Eguizabal C., Pérez-Martínez A., Solano C., Hernández-Blasco L.M., Soria B.. Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients. Biomedicines. August 2025. DOI: 10.3390/biomedicines13081801.
Impacto: 3.9. Cuartil: Q1
Mitchell R.T., Eguizabal C., Goossens E., Grynberg M., Jahnukainen K., Le Clef N., Mulder C.L., Neuhaus N., Rimmer M.P., Stukenborg J.B., van de Wetering M.D., van Pelt A.M.M., Wyns C.. ESHRE good practice recommendations on fertility preservation involving testicular tissue cryopreservation in children receiving gonadotoxic therapies. Human Reproduction. 1 August 2025. DOI: 10.1093/humrep/deaf106.
Impacto: 6.1. Cuartil: Q1
(1er decil)
Fernandez-Sojo J., Cid J., Pello O.M., Martínez-Muñoz M.E., Codinach M., Fonseca-Santos M., Santos S., Eguizabal C., Linares M., Castillo-Flores N., Azqueta C., Valvidia E., Larrea L.. A survey of cell processing practices for hematopoietic cell transplantation. Cytotherapy. April 2025. DOI: 10.1016/j.jcyt.2024.12.011.
Impacto: 3.7. Cuartil: Q1
Martin-Inaraja M., Romayor I., de Cámara A.S., Herrera L., Palacios A., Villaverde M., Santos S., Vesga M.Á., Barreña B., Aransay A.M., Anguita J., Solorzano E., Prieto M.B., Matorras R., Eguizabal C.. Generation, establishment and characterization of three pluripotent stem cell lines (CVTTHi002-A, CVTTHi003-A and CVTTHi004-A) from primary testicular somatic cells isolated from two prepuberal and one peripuberal Klinefelter Syndrome (47 XXY) patients. Stem Cell Research. March 2025. DOI: 10.1016/j.scr.2025.103657.
Impacto: 0.8. Cuartil: Q4
Hernández-Blanco C., Al-Akioui-Sanz K., Herrera L., Aguirre-Portolés C., Lozano-Ojalvo D., Pérez-Rodriguez L., Cano-Ochando J., Guerra-García P., Martín-Quirós A., Vicario J.L., Santos S., Pérez-Vaquero M.Á., Vesga M.Á., Borobia A.M., Carcas A.J., Balas A., Moreno M.Á., Pérez de Diego R., Gasior M., Soria B., Eguizabal C., Pérez-Martínez A.. The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19. iScience. 21 February 2025. DOI: 10.1016/j.isci.2024.111698.
Impacto: 4.6. Cuartil: Q1
Pardo-Rodríguez B., Baraibar A.M., Manero-Roig I., Luzuriaga J., Salvador-Moya J., Polo Y., Basanta-Torres R., Martín-Aragón D., Martín A., Romayor I., Eguizabal C., Hernández-Sánchez S., Unda F., Mato S., Ibarretxe G., Pineda J.R.. Differentiation of Human Dental Pulp Stem Cells (hDPSCs) into GABAergic Neuron-Like Cells for Personalized Cell Therapy. Neuromethods. 2025. DOI: 10.1007/978-1-0716-4783-7_8.
de Cámara A.S., Barriales D., Etxebarria A., Eguizabal C., Alvarez M.. The key role of immunomodulatory cytokines for the development of novel NK cell-based cancer therapies. International Review of Cell and Molecular Biology. 2025. DOI: 10.1016/bs.ircmb.2025.01.007.
Burón M., Etxebarria A., Álvarez M., Romayor I., Eguizabal C.. Natural killer cells in adoptive cell therapy: current landscape of genetic engineering strategies. Oncoimmunology. 2025. DOI: 10.1080/2162402X.2025.2563099.
Impacto: 6.3. Cuartil: Q1
Martin-Inaraja M., Herrera L., Santos S., Diaz-Nuñez M., Exposito A., Matorras R., Prieto M.B., Chuva De Sousa Lopes S.M., Eguizabal C.. Characterization of somatic testicular cells during human development: fetal, peripubertal, adolescent and adult human testis from healthy and infertility related disease. International Journal of Developmental Biology. 2025. DOI: 10.1387/ijdb.250005ce.
Impacto: 1.3. Cuartil: Q4
Melero I., Molina C., Eguizabal C., Alvarez M.. Intratumoral NK cell delivery combined with neutralization of the NKG2A pathway as treatment for solid cancer. Genes and Immunity. October 2024. DOI: 10.1038/s41435-024-00267-6.
Impacto: 5.0. Cuartil: Q1
Manero-Roig I., Polo Y., Pardo-Rodríguez B., Luzuriaga J., Basanta-Torres R., Martín-Aragón D., Romayor I., Martín-Colomo S., Márquez J., Gomez-Santos L., Lanore F., Humeau Y., Ibarretxe G., Eguizabal C., Larrañaga A., Pineda J.R.. Intracranial graft of bioresorbable polymer scaffolds loaded with human Dental Pulp Stem Cells in stab wound murine injury model. Methods in Cell Biology. January 2024. DOI: 10.1016/bs.mcb.2024.03.011.
Duffin K., Neuhaus N., Andersen C.Y., Barraud-Lange V., Feraille A., Braye A., Eguizabal C., Ginsberg J.P., Gook D., Goossens E., Jahnukainen K., Jayasinghe Y., Keros V., Kliesch S., Lane S., Mulder C.L., Orwig K.E., Poirot C., van Pelt A.M.M., Rimmer M.P., Rives N., Sadri-Ardekani H., Schlatt S., Safrai M., Stukenborg J.B., van de Wetering M.D., Wyns C., Mitchell R.T.. A 20-year overview of fertility preservation in boys: new insights gained through a comprehensive international survey. Human Reproduction Open. 2024. DOI: 10.1093/hropen/hoae010.
Impacto: 8.3. Cuartil: Q1
(1er decil)
Ferreras C., Hernández-Blanco C., Martín-Quirós A., Al-Akioui-Sanz K., Mora-Rillo M., Ibáñez F., Díaz-Almirón M., Cano-Ochando J., Lozano-Ojalvo D., Jiménez-González M., Goterris R., Sánchez-Zapardiel E., de Paz R., Guerra-García P., Queiruga-Parada J., Molina P., Briones M.L., Ruz-Caracuel B., Borobia A.M., Carcas A.J., Planelles D., Vicario J.L., Moreno M.Á., Balas A., Llano M., Llorente A., del Balzo Á., Cañada C., García M.Á., Calvin M.E., Arenas I., Pérez de Diego R., Eguizábal C., Soria B., Solano C., Pérez-Martínez A.. Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210). Cytotherapy. January 2024. DOI: 10.1016/j.jcyt.2023.10.002.
Impacto: 3.7. Cuartil: Q1
Czukiewska S.M., Fan X., Mulder A.A., Van Der Helm T., Hillenius S., Van Der Meeren L., Matorras R., Eguizabal C., Lei L., Koning R.I., Chuva De Sousa Lopes S.M.. Cell–cell interactions during the formation of primordial follicles in humans. Life Science Alliance. November 2023. DOI: 10.26508/lsa.202301926.
Impacto: 3.3. Cuartil: Q1
Zubia-Aranburu J., Buruaga L., Martin-Inaraja M., Rodriguez C., Santos S., Silván U., Eguizabal C., Zabala A.. Towards tailored surface topography on electrospun wound dressings for exudate absorption. Surface Innovations. 13 October 2023. DOI: 10.1680/jsuin.23.00044.
Impacto: 2.7. Cuartil: Q2
Herrera L., Martin-Inaraja M., Bengoetxea A., Vendrell A., Pérez-Fernández S., Eguizabal C., Matorras R.. Natural killer cell subsets in endometrial fluid: a pilot study of their association with the endometrial cycle and reproductive parameters. Journal of Assisted Reproduction and Genetics. September 2023. DOI: 10.1007/s10815-023-02862-4.
Impacto: 3.2. Cuartil: Q1
Demarta-Gatsi C., Andenmatten N., Jiménez-Díaz M.B., Gobeau N., Cherkaoui-Rabti M.H., Fuchs A., Díaz P., Berja S., Sánchez R., Gómez H., Ruiz E., Sainz P., Salazar E., Gil-Merino R., Mendoza L.M., Eguizabal C., Leroy D., Moehrle J.J., Tornesi B., Angulo-Barturen I.. Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model. Antimicrobial Agents and Chemotherapy. June 2023. DOI: 10.1128/aac.01574-22.
Impacto: 4.1. Cuartil: Q1
Sánchez-Guijo F., Avendaño-Solá C., Badimón L., Bueren J.A., Canals J.M., Delgadillo J., Delgado J., Eguizábal C., Fernández-Santos M.E., García-Olmo D., González-Aseguinolaza G., Juan M., Martín F., Mata R., Montserrat N., Pérez-Martínez A., Pérez-Simón J.A., Prósper F., Urbano-Ispizua Á., Zapata A.G., Sureda A., Moraleda J.M.. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV). Bone Marrow Transplantation. June 2023. DOI: 10.1038/s41409-023-01962-0.
Impacto: 4.5. Cuartil: Q1
Gonzaga A., Andreu E., Hernández-Blasco L.M., Meseguer R., Al-Akioui-Sanz K., Soria-Juan B., Sanjuan-Gimenez J.C., Ferreras C., Tejedo J.R., Lopez-Lluch G., Goterris R., Maciá L., Sempere-Ortells J.M., Hmadcha A., Borobia A., Vicario J.L., Bonora A., Aguilar-Gallardo C., Poveda J.L., Arbona C., Alenda C., Tarín F., Marco F.M., Merino E., Jaime F., Ferreres J., Figueira J.C., Cañada-Illana C., Querol S., Guerreiro M., Eguizabal C., Martín-Quirós A., Robles-Marhuenda Á., Pérez-Martínez A., Solano C., Soria B.. Rationale for combined therapies in severe-to-critical COVID-19 patients. Frontiers in Immunology. 2023. DOI: 10.3389/fimmu.2023.1232472.
Impacto: 5.7. Cuartil: Q1
Martin-Iglesias S., Herrera L., Santos S., Vesga M.Á., Eguizabal C., Lanceros-Mendez S., Silvan U.. Analysis of the impact of handling and culture on the expansion and functionality of NK cells. Frontiers in Immunology. 2023. DOI: 10.3389/fimmu.2023.1225549.
Impacto: 5.7. Cuartil: Q1
Martin-Inaraja M., Romayor I., Herrera L., Montserrat N., Eguizabal C.. Application of new technologies in embryos: From gene editing to synthetic embryos. Human Reproductive and Prenatal Genetics. 1 January 2023. DOI: 10.1016/B978-0-323-91380-5.00032-0.
Romayor I., Herrera L., Burón M., Martin-Inaraja M., Prieto L., Etxaniz J., Inglés-Ferrándiz M., Pineda J.R., Eguizabal C.. A Comparative Study of Cell Culture Conditions during Conversion from Primed to Naive Human Pluripotent Stem Cells. Biomedicines. June 2022. DOI: 10.3390/biomedicines10061358.
Impacto: 4.7. Cuartil: Q1
Bizkarguenaga M., Bruzzone C., Gil-Redondo R., SanJuan I., Martin-Ruiz I., Barriales D., Palacios A., Pasco S.T., González-Valle B., Laín A., Herrera L., Azkarate A., Vesga M.A., Eguizabal C., Anguita J., Embade N., Mato J.M., Millet O.. Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics. NMR in Biomedicine. February 2022. DOI: 10.1002/nbm.4637.
Impacto: 2.9. Cuartil: Q2
Herrera L., Martin-Inaraja M., Santos S., Inglés-Ferrándiz M., Azkarate A., Perez-Vaquero M.A., Vesga M.A., Vicario J.L., Soria B., Solano C., De Paz R., Marcos A., Ferreras C., Perez-Martinez A., Eguizabal C.. Identifying SARS-CoV-2 ‘memory’ NK cells from COVID-19 convalescent donors for adoptive cell therapy. Immunology. February 2022. DOI: 10.1111/imm.13432.
Impacto: 6.4. Cuartil: Q2
García-García I., Guerra-García P., Ferreras C., Borobia A.M., Carcas A.J., Queiruga-Parada J., Vicario J.L., Mirones I., Solano C., Eguizabal C., Soria B., Pérez-Martínez A.. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol. Trials. December 2021. DOI: 10.1186/s13063-021-05625-7.
Impacto: 2.728. Cuartil: Q4
Eguizabal C., Herrera L., Inglés-Ferrándiz M., Belmonte J.C.I.. Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing (Stem Cell Research & Therapy, (2020), 11, 1, (453), 10.1186/s13287-020-01964-5). Stem Cell Research and Therapy. December 2021. DOI: 10.1186/s13287-021-02281-1.
Impacto: 8.079. Cuartil: Q1
Álvarez-Palomo B., García-Martinez I., Gayoso J., Raya A., Veiga A., Abad M.L., Eiras A., Guzmán-Fulgencio M., Luis-Hidalgo M., Eguizabal C., Santos S., Balas A., Alenda R., Sanchez-Gordo F., Verdugo L.P., Villa J., Carreras E., Vidal F., Madrigal A., Herrero M.J., Rudilla F., Querol S.. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells. Stem Cell Research and Therapy. December 2021. DOI: 10.1186/s13287-021-02301-0.
Impacto: 8.079. Cuartil: Q1
Herrera L., Santos S., Vesga M.A., Carrascosa T., Garcia-ruiz J.C., Pérez-martínez A., Juan M., Eguizabal C.. The race of CAR therapies: CAR-NK cells for fighting B-cell hematological cancers. Cancers. November-1 2021. DOI: 10.3390/cancers13215418.
Impacto: 6.575. Cuartil: Q1
Fan X., Moustakas I., Torrens-Juaneda V., Lei Q., Hamer G., Louwe L.A., Pilgram G.S.K.K.S., Matorras R., Eguizabal C., Van Der Westerlaken L., Mei H., De Sousa Lopes S.M.C.. Transcriptional progression during meiotic prophase I reveals sex-specific features and X chromosome dynamics in human fetal female germline. PLoS Genetics. 9 September 2021. DOI: 10.1371/journal.pgen.1009773.
Impacto: 6.02. Cuartil: Q1
Pérez-Martínez A., Mora-Rillo M., Ferreras C., Guerra-García P., Pascual-Miguel B., Mestre-Durán C., Borobia A.M., Carcas A.J., Queiruga-Parada J., García I., Sánchez-Zapardiel E., Gasior M., De Paz R., Marcos A., Vicario J.L., Balas A., Moreno M.A., Eguizabal C., Solano C., Arribas J.R., Buckley R.d.M., Montejano R., Soria B.. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE). EClinicalMedicine. September 2021. DOI: 10.1016/j.eclinm.2021.101086.
Impacto: 17.033. Cuartil: Q1
(1er decil)
Martin-Inaraja M., Ferreira M., Taelman J., Eguizabal C., Chuva De Sousa Lopes S.M.. Improving in vitro culture of human male fetal germ cells. Cells. August 2021. DOI: 10.3390/cells10082033.
Impacto: 7.666. Cuartil: Q2
Mikkelsen C., Mori G., van Walraven S.M., Castrén J., Zahra S., MacLennan S., Seidel K., Fontana S., Veropalumbo E., Cannata L., Pupella S., Kvist M., Happel M., Korkalainen P., Chandrasekar A., Paulus U., Bokhorst A., Wulff B., Fernandez-Sojo J., Eguizabal C., Urbano F., Vesga M.A., van Kraaij M., Merz E.M., van den Hurk K., Hansen M.B., Slot E., Ullum H.. How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE project. Vox Sanguinis. March 2021. DOI: 10.1111/vox.13028.
Impacto: 2.996. Cuartil: Q3
Mikkelsen C., Mori G., van Walraven S.M., Castrén J., Zahra S., MacLennan S., Seidel K., Fontana S., Veropalumbo E., Cannata L., Pupella S., Kvist M., Happel M., Korkalainen P., Wulff B., Fernandez-Sojo J., Eguizabal C., Urbano F., Vesga M.A., Pozenel P., van Kraaij M., Hansen M.B., Slot E., Ullum H.. Putting the spotlight on donation-related risks and donor safety – are we succeeding in protecting donors?. Vox Sanguinis. March 2021. DOI: 10.1111/vox.13014.
Impacto: 2.996. Cuartil: Q3
Ferreras C., Pascual-Miguel B., Mestre-Durán C., Navarro-Zapata A., Clares-Villa L., Martín-Cortázar C., De Paz R., Marcos A., Vicario J.L., Balas A., García-Sánchez F., Eguizabal C., Solano C., Mora-Rillo M., Soria B., Pérez-Martínez A.. SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy. Frontiers in Cell and Developmental Biology. 25 February 2021. DOI: 10.3389/fcell.2021.620730.
Impacto: 6.081. Cuartil: Q1
De Wert G., Van Der Hout S., Goddijn M., Vassena R., Frith L., Vermeulen N., Eichenlaub-Ritter U., Blanchet V., D'angelo A., Eguizabal C., Geril A., Heindryckx B., Mertes H., Ombelet W., Rautakallio-Hokkanen S., Strowitzki T., Tapanainen J., Tarlatzis B.C., Van Den Eede B., Westin C.. The ethics of preconception expanded carrier screening in patients seeking assisted reproduction. Human Reproduction Open. 2021. DOI: 10.1093/hropen/hoaa063.
Impacto: 7.13. Cuartil: Q1
(1er decil)
Inglés-Ferrándiz M., Martin-Inaraja M., Herrera L., Villaverde M., Santos S., Vesga M.A., Garreta E., Martín-Ruiz I., Aransay A.M., Anguita J., Barreña B., Allende L.M., Gonzalez-Granado L.I., Eguizabal C.. Generation, establishment and characterization of a pluripotent stem cell line (CVTTHi001-A) from primary fibroblasts isolated from a patient with activated PI3 kinase delta syndrome (APDS2). Stem Cell Research. December 2020. DOI: 10.1016/j.scr.2020.102082.
Impacto: 2.02. Cuartil: Q4
Eguizabal C., Herrera L., Inglés-Ferrándiz M., Izpisua Belmonte J.C.. Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing. Stem Cell Research and Therapy. 1 December 2020. DOI: 10.1186/s13287-020-01964-5.
Impacto: 6.832. Cuartil: Q1
Herrera L., Juan M., Eguizabal C.. Purification, Culture, and CD19-CAR Lentiviral Transduction of Adult and Umbilical Cord Blood NK Cells. Current Protocols in Immunology. December 2020. DOI: 10.1002/cpim.108.
Herrera L., Santos S., Vesga M.A., Anguita J., Martin-Ruiz I., Carrascosa T., Juan M., Eguizabal C.. Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells. Scientific Reports. 1 December 2019. DOI: 10.1038/s41598-019-55239-y.
Impacto: 3.998. Cuartil: Q1
Eguizabal C., Aran B., Chuva De Sousa Lopes S.M., Geens M., Heindryckx B., Panula S., Popovic M., Vassena R., Veiga A.. Two decades of embryonic stem cells: A historical overview. Human Reproduction Open. 29 January 2019. DOI: 10.1093/hropen/hoy024.
Santos S., Rodriguez C., Eguizabal C., Balas A., Vicario J.. Characterization of the novel HLA-A*80:04 allele identified in a Spanish volunteer donor. HLA. October 2018. DOI: 10.1111/tan.13372.
Impacto: 2.785. Cuartil: Q2
Puig I., Tenbaum S.P., Chicote I., Arqués O., Martínez-Quintanilla J., Cuesta-Borrás E., Ramírez L., Gonzalo P., Soto A., Aguilar S., Eguizabal C., Caratù G., Prat A., Argilés G., Landolfi S., Casanovas O., Serra V., Villanueva A., Arroyo A.G., Terracciano L., Nuciforo P., Seoane J., Recio J.A., Vivancos A., Dienstmann R., Tabernero J., Palmer H.G.. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence. Journal of Clinical Investigation. 31 August 2018. DOI: 10.1172/JCI96393.
Impacto: 12.282. Cuartil: Q1
(1er decil)
Niederberger C., Pellicer A., Cohen J., Gardner D.K., Palermo G.D., O'Neill C.L., Chow S., Rosenwaks Z., Cobo A., Swain J.E., Schoolcraft W.B., Frydman R., Bishop L.A., Aharon D., Gordon C., New E., Decherney A., Tan S.L., Paulson R.J., Goldfarb J.M., Brännström M., Donnez J., Silber S., Dolmans M.M., Simpson J.L., Handyside A.H., Munné S., Eguizabal C., Montserrat N., Izpisua Belmonte J.C., Trounson A., Simon C., Tulandi T., Giudice L.C., Norman R.J., Hsueh A.J., Sun Y., Laufer N., Kochman R., Eldar-Geva T., Lunenfeld B., Ezcurra D., D'Hooghe T., Fauser B.C.J.M., Tarlatzis B.C., Meldrum D.R., Casper R.F., Fatemi H.M., Devroey P., Galliano D., Wikland M., Sigman M., Schoor R.A., Goldstein M., Lipshultz L.I., Schlegel P.N., Hussein A., Oates R.D., Brannigan R.E., Ross H.E., Pennings G., Klock S.C., Brown S., Van Steirteghem A., Rebar R.W., LaBarbera A.R.. Forty years of IVF. Fertility and Sterility. 15 July 2018. DOI: 10.1016/j.fertnstert.2018.06.005.
Impacto: 5.411. Cuartil: Q1
(1er decil)
Fernandes M.G., He N., Wang F., Van Iperen L., Eguizabal C., Matorras R., Roelen B.A.J., Chuva De Sousa Lopes S.M.. Human-specific subcellular compartmentalization of P-element induced wimpy testis-like (PIWIL) granules during germ cell development and spermatogenesis. Human Reproduction. 1 February 2018. DOI: 10.1093/humrep/dex365.
Impacto: 5.506. Cuartil: Q1
(1er decil)
Eguizabal C., Montserrat N., Izpisua Belmonte J.C.. Gene Editing Nuclear and Mitochondrial DNA. Encyclopedia of Reproduction: Volume 1-6, Second Edition. 1 January 2018. DOI: 10.1016/B978-0-12-801238-3.64914-0.
Eguizabal C., Montserrat N., Izpisua Belmonte J.C.. Application of gene-editing technologies in embryos and their potential for gene therapy. Human Reproductive and Prenatal Genetics. 1 January 2018. DOI: 10.1016/B978-0-12-813570-9.00030-9.
Eguizabal C., Montserrat N., Izpisua Belmonte J.C.. Gene editing nuclear and mitochondrial DNA. Encyclopedia of Reproduction. 1 January 2018. DOI: 10.1016/B978-0-12-801238-3.64914-0.
Herrera L., Salcedo J.M., Santos S., Vesga M.Á., Borrego F., Eguizabal C.. OP9 feeder cells are superior to M2-10B4 cells for the generation of mature and functional natural killer cells from umbilical cord hematopoietic progenitors. Frontiers in Immunology. 30 June 2017. DOI: 10.3389/fimmu.2017.00755.
Impacto: 5.511. Cuartil: Q1
Garreta E., Marco A., Eguizábal C., Tarantino C., Samitier M., Badiola M., Gutiérrez J., Samitier J., Montserrat N.. Pluripotent stem cells and skeletal muscle differentiation: Challenges and immediate applications. The Plasticity of Skeletal Muscle: From Molecular Mechanism to Clinical Applications. 1 January 2017. DOI: 10.1007/978-981-10-3292-9_1.
Santos S., Arroyo J.L., Eguizabal C., Balas A., Vicario J.L.. Genomic full-length sequence of two new HLA-C alleles, HLA-C*04:239 and HLA-C*05:137. HLA. 1 December 2016. DOI: 10.1111/tan.12920.
Impacto: 0.0. Cuartil: Q4
Zenarruzabeitia O., Vitallé J., García-Obregón S., Astigarraga I., Eguizabal C., Santos S., Simhadri V.R., Borrego F.. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Scientific Reports. 6 September 2016. DOI: 10.1038/srep32693.
Impacto: 4.259. Cuartil: Q1
Eguizabal C., Herrera L., De Oñate L., Montserrat N., Hajkova P., Izpisua Belmonte J.C.. Characterization of the Epigenetic Changes During Human Gonadal Primordial Germ Cells Reprogramming. Stem Cells. 1 September 2016. DOI: 10.1002/stem.2422.
Impacto: 5.599. Cuartil: Q1
Pérez Vaquero M.A., Gorria C., Lezaun M., López F.J., Monge J., Eguizabal C., Vesga M.A.. Optimization of the management of platelet concentrate stocks in the Basque Country using mathematical simulation. Vox Sanguinis. 1 May 2016. DOI: 10.1111/vox.12377.
Impacto: 2.192. Cuartil: Q3
Santos S., Azkarate M., Eguizabal C., Balas A., Vicario J.L.. Genomic sequence of HLA-B*41:43, a new HLA-B allele generated by an intralocus recombination mechanism. HLA. 2016. DOI: 10.1111/tan.12725.
Impacto: 0.0. Cuartil: Q4
Azkarate M., Santos S., Eguizabal C., Balas A., Vicario J.. The new HLA-A*24:321 shows one conservative amino acid replacement compared with HLA-A*24:02:01. HLA. 1 January 2016. DOI: 10.1111/tan.12701.
Impacto: 0.0. Cuartil: Q4
Zenarruzabeitia O., Vitallé J., Eguizabal C., Simhadri V.R., Borrego F.. The biology and disease relevance of CD300a, an inhibitory receptor for phosphatidylserine and phosphatidylethanolamine. Journal of Immunology. 1 June 2015. DOI: 10.4049/jimmunol.1500304.
Impacto: 4.985. Cuartil: Q1
Vassena R., Eguizabal C., Heindryckx B., Sermon K., Simon C., Van Pelt A.M.M., Veiga A., Zambelli F.. Stem cells in reproductive medicine: Ready for the patient?. Human Reproduction. 9 April 2015. DOI: 10.1093/humrep/dev181.
Impacto: 4.621. Cuartil: Q1
(1er decil)
Azcarate M., Santos S., Balas A., Eguizabal C., Vicário J.L.. A new HLA-B allele, B*49:34, sequenced in a Spanish individual. Tissue Antigens. 1 April 2015. DOI: 10.1111/tan.12546.
Impacto: 2.046. Cuartil: Q2
Eguizabal C., Zenarruzabeitia O., Monge J., Santos S., Vesga M.A., Maruri N., Arrieta A., Riñón M., Tamayo-Orbegozo E., Amo L., Larrucea S., Borrego F.. Natural killer cells for cancer immunotherapy: Pluripotent stem cells-derived NK cells as an immunotherapeutic perspective. Frontiers in Immunology. 2014. DOI: 10.3389/fimmu.2014.00439.
Amo L., Tamayo-Orbegozo E., Maruri N., Eguizabal C., Zenarruzabeitia O., Riñón M., Arrieta A., Santos S., Monge J., Vesga M.A., Borrego F., Larrucea S.. Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. Frontiers in Oncology. 2014. DOI: 10.3389/fonc.2014.00245.
Tiscornia G., Vivas E.L., Matalonga L., Berniakovich I., Monasterio M.B., Eguizábal C., Gort L., González F., Mellet C.O., Fernández J.M.G., Ribes A., Veiga A., Belmonte J.C.I.. Corrigendum to neuronopathic gaucher's disease: Induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds [Human Molecular Genetics 22, 4, (2013) 633-645] DOI: 10.1093/hmg/dds471. Human Molecular Genetics. January 2014. DOI: 10.1093/hmg/ddt507.
Impacto: 6.393. Cuartil: Q1
Díez-Torre A., Díaz-Núñez M., Eguizábal C., Silván U., Aréchaga J.. Evidence for a role of matrix metalloproteinases and their inhibitors in primordial germ cell migration. Andrology. September 2013. DOI: 10.1111/j.2047-2927.2013.00109.x.
Impacto: 0.0. Cuartil: Q4
Eguizabal C., Montserrat N., Veiga A., Belmonte J.I.. Dedifferentiation, transdifferentiation, and reprogramming: Future directions in regenerative medicine. Seminars in Reproductive Medicine. 2013. DOI: 10.1055/s-0032-1331802.
Impacto: 3.0. Cuartil: Q1
Tiscornia G., Lorenzo Vivas E., Matalonga L., Berniakovich I., Barragán Monasterio M., Eguizábal C., Gort L., González F., Ortiz mellet C., García Fernández J.M., Ribes A., Veiga A., Izpisua Belmonte J.C.. Neuronopathic Gaucher's disease: Induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds. Human Molecular Genetics. February 2013. DOI: 10.1093/hmg/dds471.
Impacto: 6.677. Cuartil: Q1
Montserrat N., de Oñate L., Garreta E., González F., Adamo A., Eguizábal C., Häfner S., Vassena R., Belmonte J.C.I.. Generation of feeder-free pig induced pluripotent stem cells without Pou5f1. Cell Transplantation. 2012. DOI: 10.3727/096368911X601019.
Impacto: 4.422. Cuartil: Q1
Eguizabal C., Montserrat N., Vassena R., Barragan M., Garreta E., Garcia-Quevedo L., Vidal F., Giorgetti A., Veiga A., Izpisua Belmonte J.C.. Complete meiosis from human induced pluripotent stem cells. Stem Cells. August 2011. DOI: 10.1002/stem.672.
Impacto: 7.781. Cuartil: Q1
(1er decil)
Montserrat N., Garreta E., González F., Gutiérrez J., Eguizábal C., Ramos V., Borrós S., Belmonte J.C.I.. Simple generation of human induced pluripotent stem cells using poly-β-amino esters as the non-viral gene delivery system. Journal of Biological Chemistry. 8 April 2011. DOI: 10.1074/jbc.M110.168013.
Impacto: 4.773. Cuartil: Q1
Díez-Torre A., Andrade R., Eguizábal C., López E., Arluzea J., Silió M., Aréchaga J.. Reprogramming of melanoma cells by embryonic microenvironments. International Journal of Developmental Biology. 2009. DOI: 10.1387/ijdb.093021ad.
Impacto: 2.161. Cuartil: Q4
Eguizabal C., Shovlin T.C., Durcova-Hills G., Surani A., McLaren A.. Generation of primordial germ cells from pluripotent stem cells. Differentiation. September 2009. DOI: 10.1016/j.diff.2009.07.001.
Impacto: 3.311. Cuartil: Q2
Eguizabal C., Boyano M.D., Díez-Torre A., Andrade R., Andollo N., De Felici M., Aréchaga J.. Interleukin-2 induces the proliferation of mouse primordial germ cells in vitro. International Journal of Developmental Biology. 2007. DOI: 10.1387/ijdb.072442ce.
Impacto: 2.83. Cuartil: N/D
Andollo N., Boyano M., Andrade R., Zalduendo M., Eguizabal C., Asumendi A., Arlucea J., Aréchaga J.. Structural and functional preservation of specific sequences of DNA and mRNA in apoptotic bodies from ES cells. Apoptosis. March 2005. DOI: 10.1007/s10495-005-0815-5.
Impacto: 4.497. Cuartil: N/D